Factsheets may be reprinted or adapted for non-profit use. Please credit UK-CAB and any other sources.

Key:
NRTI - nucleoside/nucleotide reverse transcriptase inhibitors (nukes)

NNRTI - non-nucleoside/nucleotide reverse transcriptase inhibitors (non-nukes)

PI - protease inhibitor

EI - entry inhibitor

FI - fusion inhibitor

CCR5 - chemokine co-receptor 5 (chemokine receptor which HIV uses as a coreceptor to gain entry into macrophages)

INI - intergrase inhibitor

HIV Drugs By Manufacturer

Download as a Word Document [120 Kb]
Download as a PDF File [88 Kb]

Common Name	Generic name/abbreviations	Trade Name	Class

GlaxoSmithKline (GSK)
AZT, ZDV	zidovudine	Retrovir	NRTI
3TC	lamuvidine	Epvir	NRTI
AZT + 3TC	zidovudine+lamuvidine	Combivir	NRTI
ABC	abacavir	Ziagen	NRTI
AZT+3TC+abacavir	zidovudine+lamivudine+abacavir	Trizivir	NRTI
abacavir + 3TC	abacavir+lamuvidine	Kivexa	NRTI
FPV	fosamprenavir	Telzvir	PI

Pipeline Drugs
IDX899			NNRTI (Phase1/ 2)
GSK364735			INI(Phase 1)

Bristol-Myers Squibb (BMS)
ddI	didanosine	Videx	NRTI
d4T	stavudine	Zerit	NRTI
EFV	efavirenz	Sustiva (EU)	NNRTI
ATV	atazanavir	Reyataz	PI
Atripla (with Gilead)	efavirenz+FTC+tenofovir	Atriprila	NNRTI+2NRTIs

Gilead Sciences
TDF	tenofovir	Viread	NRTI
FTC	emtricitabine	Emtriva	NRTI
Tenofovir+ FTC	emtricitabine+tenofovir	Truvada	NRTI
Atripla (with BMS)	efavirenz+FTC+tenofovir	Atriprila	NNRTI+2NRTIs

Pipeline Drugs
elvitegravir			INI (Phase 3)

Tibotec
ETR	etravirine	Intelence	NNRTI
DRV	darunivir	Prezista	PI

Pipeline Drugs
TMC278	rilpvirine		NNRTI (Phase 3)

Abbott
RTV	ritonavir	Norvir	PI
LPV	lopinavir+ritonavir	Kaletra+Aluvia	PI

Pfizer
DLV	delavirdine	Rescriptor	NNRTI
NFV	nelfinavir	Viracept	PI
MVC	maraviroc	Celsentri (Selzentry)	EI

Pipeline Drugs
UK 543,061			NNRTI (Phase 1)

Boehringer
NVP	nevirapine	Viramune	NNRTI
TPV	tipranavir	Aptivus	PI

Pipeline Drugs
BILR 355			NNRTI (Phase 2)

Roche
SQV	saquinavir	Invirase	PI
T-20	enfuvirtide	Fuzeon	FI

Merck
IDV	indinavir	Crixivan	PI
RGV	raltegravir	Isentress	INI

Schering
Pipeline Drugs
Vicriviroc	VCV		EI (CCR5) (Phase 3)

Co-infections

Hepatatis C

Drugs that are used in combination:

Schering Plough:

pegylated interferon: (PegIFN) given by injection : There are two types of PEG interferon (Aalpha-2a, trade name pagasys) and Alpha-2b, trade name Peglntron or ViraferonPeg

Roche:

ribavirin: RBV, given orally

Pipeline Drugs/Clinical trials: information can be found at:

http://www.hcvadvocate.org/hepatitis/hepC/HCVDrugs.html

http://www.treatmentactiongroup.org

TB Drugs:

1^st line drugs: Generic drugs

ethambutol (EMB or E)
isoniazid (INH or H)
pyrazinamide (PZA or Z)
rifampicin (RMP or R)
streptomycin (STM or S)

2^nd line drugs: (SLDs)

There are six classes of SLDs used for the treatment of TB. A drug may be classed as second-line instead of first-line for one of two possible reasons: it may be less effective than the first-line drugs (e.g., p-aminosalicylic acid); or, it may have toxic side-effects (e.g., cycloserine); or it may be unavailable in many developing countries (e.g., fluoroquinolones):

aminoglycosides: e.g., amikacin (AMK), kanamycin (KM)
polypeptides: e.g., capreomycin, viomycin, enviomycin
fluoroquinolones: e.g., ciprofloxacin (CIP), levofloxacin, moxifloxacin (MXF)
thioamides: e.g. ethionamide, prothionamide
cycloserine (the only antibiotic in its class)
p-aminosalicylic acid (PAS or P)

Other drugs that may be useful, but are not on the World Health Organisation (WHO) list of SLDs:

These drugs may be considered "third-line drugs" and are either because they are not very effective (e.g., clarithromycin) or because their efficacy has not been proven (e.g., linezolid, R207910). Rifabutin is effective, but is not included on the WHO list because for most developing countries, it is impractically expensive.

rifabutin
macrolides: e.g., clarithromycin (CLR)
linezolid (LZD)
thioacetazone (T)
thioridazine
arginine
vitamin D
R207910

Pipeline Drugs/Clinical trials: information can be found at:
http://www.treatmentactiongroup.org